Neurogene (NGNE) Return on Capital Employed [ROCE] (2014 - 2026)
Neurogene (NGNE) posted Return on Capital Employed [ROCE] of -52.25% for Q2 2026, down 19.35 percentage points from -32.90% a year earlier and down 9.15 percentage points from the prior quarter.
Powered by 
Analysis
Neurogene (NGNE) Return on Capital Employed [ROCE] (2014 - 2026) Analysis & Trends
For FY2025, Neurogene's Return on Capital Employed [ROCE] came in at -34.94%, down 3.65 percentage points from FY2024.
- Annual Return on Capital Employed [ROCE] shows a five-year change of -15.20 percentage points (FY2020 to FY2025).
- In prior years, Neurogene's Return on Capital Employed [ROCE] was -31.29% in FY2024 (+7.59 pp), -38.88% in FY2023 (+4.72 pp), -43.60% in FY2022 (-9.55 pp) and -34.05% in FY2021 (-14.31 pp).
- The Q2 2026 figure stands as the lowest quarterly Return on Capital Employed [ROCE] since Q3 2023.
- On a year-over-year basis, Return on Capital Employed [ROCE] has declined in each of the last three quarters, with an average year-over-year change of +0.58 percentage points over the last eight quarters.
- The strongest year-over-year quarter for Return on Capital Employed [ROCE] in the past five years was Q1 2024, with a gain of 24.92 percentage points; the weakest was Q2 2022, with a drop of 22.06 percentage points.
- According to Business Quant data, Return on Capital Employed [ROCE] for the three prior quarters was -43.10% (Q1 2026), -38.01% (Q4 2025) and -35.02% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 46.74% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 17.83% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 17.92% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 6.28% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 19.32% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 9.54% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 16.66% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 11.86% |
| 10 | Neurogene | 578.46 Mn | 578.46 Mn | - | -52.25% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -52.25% |
| Mar 31, 2026 | -43.10% |
| Dec 31, 2025 | -38.01% |
| Sep 30, 2025 | -35.02% |
| Jun 30, 2025 | -32.90% |
| Mar 31, 2025 | -28.82% |
| Dec 31, 2024 | -35.19% |
| Sep 30, 2024 | -48.55% |
| Jun 30, 2024 | -39.46% |
| Mar 31, 2024 | -31.11% |
| Dec 31, 2023 | -41.76% |
| Sep 30, 2023 | -60.66% |
| Jun 30, 2023 | -55.73% |
| Mar 31, 2023 | -56.03% |
| Dec 31, 2022 | -50.79% |
| Sep 30, 2022 | -49.37% |
| Jun 30, 2022 | -46.23% |
| Mar 31, 2022 | -41.13% |
| Dec 31, 2021 | -37.71% |
| Sep 30, 2021 | -33.72% |
API Access
Neurogene Return on Capital Employed [ROCE] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=NGNE&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-capital-employed-[roce]", "ticker": "NGNE", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=NGNE&period=max&api_key=YOUR_API_KEY");
const data = await res.json();